Patents by Inventor Benjamin R. tenOever

Benjamin R. tenOever has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240024414
    Abstract: This disclosure provides methods for preventing or treating influenza virus infection or influenza virus diseases in a subject, comprising administering to a subject in need thereof an L7Ae protein or a fragment/variant thereof, or a nucleic acid molecule comprising a polynucleotide encoding an L7Ae protein or a fragment/variant thereof. Also provided are compositions suitable for use in these methods.
    Type: Application
    Filed: September 20, 2021
    Publication date: January 25, 2024
    Applicant: Icahn School of Medicine at Mount Sinai
    Inventor: Benjamin R. Tenoever
  • Publication number: 20230088902
    Abstract: This disclosure provides a CRISPR-Cas system with both RNase and Dnase activity for genetic editing and methods of use thereof. The disclosed CRISPR-Cas system can function in a cell-specific manner, which enables in vivo editing while mitigating the risk of off-target effects.
    Type: Application
    Filed: January 27, 2021
    Publication date: March 23, 2023
    Inventors: Benjamin R. Tenoever, Rasmus Moeller
  • Publication number: 20170321192
    Abstract: Described herein are modified RNA virus gene segments and nucleic acids encoding modified RNA virus gene segments. Also described herein are recombinant RNA viruses comprising modified RNA virus gene segments and the use of such recombinant RNA viruses for the prevention and treatment of disease.
    Type: Application
    Filed: April 6, 2017
    Publication date: November 9, 2017
    Applicant: Icahn School of Medicine at Mount Sinai
    Inventor: Benjamin R. tenOever
  • Publication number: 20130209406
    Abstract: Described herein are modified RNA virus gene segments and nucleic acids encoding modified RNA virus gene segments. Also described herein are recombinant RNA viruses comprising modified RNA virus gene segments and the use of such recombinant RNA viruses for the prevention and treatment of disease.
    Type: Application
    Filed: June 6, 2011
    Publication date: August 15, 2013
    Inventor: Benjamin R. tenOever